NIMH Director Admitted Billions in Research Didn’t Result in Better Mental Health Outcomes
🔴 WATCH THE FULL EPISODE: https://ept.ms/3Nxe1qoShow more Has the massive rollout of psychiatric drugs over recent decades actually led to better outcomes for patients? The evidence says no. Even former NIMH Director Thomas Insel admitted that despite overseeing ~$20 billion in neuroscience and genetics research during his 13-year tenure, clinical outcomes for patients did not improve. Recovery rates didn’t increase and hospitalization and suicide rates didn’t decrease. Yet instead of rethinking the approach, the field doubles down, says David Cohen, Professor for Social Welfare at UCLA’s Luskin School of Public Affairs. “Since Insel left, the NIMH has doubled down on biological, so-called precision medicine genome [research]... They're going deeper into the infinite reality of our substrates, from one gene now to 300 gene variants that only explain 2% or 3% of what might be a liability for schizophrenia…The correlation with being schizophrenic gets smaller and smaller and smaller.” Cohen argues for a fundamental shift: What we label “mental illness” is often extraordinary despair, loss of hope, and inability to cope with life's tragedies. Families used to be the first line of defense in such situations, he told me, but this is no longer the case: “Our families today are everywhere else but close to us. As a rule, I think we've passed that halfway point where everyone's dispersed. So you're basically on your own.” And that’s why, he believes, our psychologists and psychiatrists must adopt a better model: Instead of immediately prescribing psychiatric drugs, spending time with patients, listening to them and their stories and enabling them, as he puts it, “to repair broken bonds.” Show less